Literature DB >> 6018754

The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.

S S Shapiro.   

Abstract

Investigations were undertaken of the chemical nature and kinetics of interaction of three acquired inhibitors of Factor VIII. The inhibition was stoichiometric, one molecule of inhibitor (or one site on a molecule) being required to inactivate one molecule of Factor VIII. All three inhibitors were found to be monotypic antibodies of class IgG, Type K (gamma(2) kappa(2)). This appears to be the second syndrome due to the production of monotypic antibody, and the first instance involving IgG immunoglobulins.

Mesh:

Substances:

Year:  1967        PMID: 6018754      PMCID: PMC297033          DOI: 10.1172/JCI105517

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  CIRCULATING ANTICOAGULANT AGAINST FACTOR 8 COEXISTENT WITH SOME IMMUNOLOGICAL REACTIONS IN A FEMALE.

Authors:  S LOPACIUK; A NALECZYNSKA; H CZAJA; I WALEWSKA; S PAWELSKI
Journal:  Thromb Diath Haemorrh       Date:  1964-07-31

Review 2.  PLASMA CELL MYELOMA: GAMMA GLOBULIN SYNTHESIS AND STRUCTURE. A REVIEW OF BIOCHEMICAL AND CLINICAL DATA, WITH THE DESCRIPTION OF A NEWLY-RECOGNIZED AND RELATED SYNDROME, "H-GAMMA-2-CHAIN (FRANKLIN'S) DISEASE.

Authors:  E F OSSERMAN; K TAKATSUKI
Journal:  Medicine (Baltimore)       Date:  1963-11       Impact factor: 1.889

3.  STRUCTURAL BASIS FOR THE DIFFERENCES BETWEEN TYPE I AND TYPE II HUMAN GAMMA-GLOBULIN MOLECULES.

Authors:  J L FAHEY
Journal:  J Immunol       Date:  1963-10       Impact factor: 5.422

4.  STRUCTURAL STUDIES OF THE IMMUNOGLOBULINS. I. THE TRYPTIC PEPTIDES OF BENCE-JONES PROTEINS.

Authors:  F W PUTNAM; C W EASLEY
Journal:  J Biol Chem       Date:  1965-04       Impact factor: 5.157

5.  A CIRCULATING ANTICOAGULANT INHIBITING ANTIHAEMOPHILIC GLOBULIN.

Authors:  P H PINKERTON; J H DAGG; F TAYLOR
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

6.  Kinetics of the inhibition of Cypridina luciferase by specific antibody.

Authors:  F I TSUJI; D L DAVIS; R SOWINSKI
Journal:  J Immunol       Date:  1960-06       Impact factor: 5.422

7.  ELECTROPHORETIC ISOLATION OF A CIRCULATING ANTICOAGULANT.

Authors:  F L Munro; M P Munro
Journal:  J Clin Invest       Date:  1946-11       Impact factor: 14.808

8.  A cold agglutinin of the IgA class.

Authors:  C D Angevine; B R Andersen; E V Barnett
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

9.  A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillin.

Authors:  H I Glueck; R Hong
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

10.  Physical properties of the red cell agglutinins in acquired hemolytic anemia.

Authors:  H H FUDENBERG; H G KUNKEL
Journal:  J Exp Med       Date:  1957-11-01       Impact factor: 14.307

View more
  13 in total

1.  [Prostate carcinoma associated spontaneous factor VIII:C inhibitor hemophilia. Successful therapy of severe hemorrhagic complication with porcine factor VIII in a 75-year-old patient].

Authors:  T Orth; M Schnütgen; W Herr; W J Mayet; W Dippold; R Wanitschke; K H Meyer zum Buschenfelde
Journal:  Med Klin (Munich)       Date:  1997-04-15

2.  The properties of immune complexes formed by human antibodies to factor VIII.

Authors:  J Lazarchick; L W Hoyer
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

3.  Pregnancy and antibody to factor VIII.

Authors:  J Voke; E Letsky
Journal:  J Clin Pathol       Date:  1977-10       Impact factor: 3.411

Review 4.  Hemophilia.

Authors:  A S Sethi
Journal:  Indian J Pediatr       Date:  1970-06       Impact factor: 1.967

5.  Serum immunoglobulins in patients with congenital coagulation defects and their relatives.

Authors:  A M Mingers; C Mietens; J Ströder
Journal:  Z Kinderheilkd       Date:  1971

6.  [The weak inhibitors of factor VIII in patients with hemophilia A].

Authors:  G Mayer; G Noel; V Kalogjera; R Waitz
Journal:  Blut       Date:  1969

7.  Lupus anticoagulant after measles.

Authors:  W Muntean; W Petek
Journal:  Eur J Pediatr       Date:  1980-08       Impact factor: 3.183

8.  [Current aspects on evaluation of assays of factor-VIII activity, factor-VIII associated protein and factor-VIII neutralizing antibody (author's transl)].

Authors:  G Hintz
Journal:  Blut       Date:  1978-02

Review 9.  Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodies.

Authors:  Géraldine Lavigne-Lissalde; Chantal Rothschild; Claire Pouplard; Priscilla Lapalud; Yves Gruel; Jean-François Schved; Claude Granier
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

10.  Factor V anticoagulants: clinical, biochemical, and immunological observations.

Authors:  D I Feinstein; S I Rapaport; W G McGehee; M J Patch
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.